{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:52:10Z","timestamp":1694631130023},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"24","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Modulation of cytosolic phospholipase A2 (PLA2) expression levels and production of its metabolites have been reported in several tumor types, indicating involvement of arachidonic acid and its derivatives in tumorigenesis. Following our demonstration that the PLA2 group IV isoform \u03b1 (PLA2IV\u03b1) controls TSH-independent growth of normal thyroid (PCCl3) cells, we have investigated the mitogenic role of PLA2IV\u03b1 in rat thyroid cells transformed by the RET\/PTC oncogenes (PC-PTC cells). We now report that PLA2IV\u03b1 acts downstream of the RET\/PTC oncogenes in a novel pathway controlling RET-dependent cell proliferation. In addition, we show that PLA2IV\u03b1 is in its phosphorylated\/active form not only in RET\/PTC-transformed cells and in cells derived from human papillary carcinomas but also in lysates from tumor tissues, thus relating constitutive activation of PLA2IV\u03b1 to RET\/PTC-dependent tumorigenesis. Moreover, p38 stress-activated protein kinase is the downstream effector of RET\/PTC that is responsible for PLA2IV\u03b1 phosphorylation and activity. In summary, our data elucidate a novel mechanism in the control of thyroid tumor cell growth that is induced by the RET\/PTC oncogenes and which is distinguishable from that of other oncogenes, such as BRAF. This mechanism is mediated by PLA2IV\u03b1 and should be amenable to targeted pharmacologic intervention. [Cancer Res 2007;67(24):11769\u201378]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-1997","type":"journal-article","created":{"date-parts":[[2007,12,18]],"date-time":"2007-12-18T18:52:12Z","timestamp":1198003932000},"page":"11769-11778","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cytosolic Phospholipase A2\u03b1 Regulates Cell Growth in <i>RET\/PTC<\/i>-Transformed Thyroid Cells"],"prefix":"10.1158","volume":"67","author":[{"given":"Stefania","family":"Mariggio\u0300","sequence":"first","affiliation":[{"name":"1Department of Cell Biology and Oncology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice Maria","family":"Filippi","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Oncology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"Iurisci","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Oncology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana Katia","family":"Dragani","sequence":"additional","affiliation":[{"name":"2Environmental Sciences Center, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"De Falco","sequence":"additional","affiliation":[{"name":"3Istituto di Endocrinologia ed Oncologia Sperimentale del CNR \u201cG. Salvatore,\u201d c\/o Dipartimento di Biologia e Patologia Cellulare e Molecolare, University \u201cFederico II,\u201d Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Santoro","sequence":"additional","affiliation":[{"name":"3Istituto di Endocrinologia ed Oncologia Sperimentale del CNR \u201cG. Salvatore,\u201d c\/o Dipartimento di Biologia e Patologia Cellulare e Molecolare, University \u201cFederico II,\u201d Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Corda","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Oncology and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2007,12,18]]},"reference":[{"key":"2022061623351548900_B1","doi-asserted-by":"crossref","unstructured":"Diaz BL, Arm JP. Phospholipase A2. Prostaglandins Leukot Essent Fatty Acids\u20082003; 69: 87\u201397.","DOI":"10.1016\/S0952-3278(03)00069-3"},{"key":"2022061623351548900_B2","doi-asserted-by":"crossref","unstructured":"Leslie CC. Regulation of arachidonic acid availability for eicosanoid production. Biochem Cell Biol\u20082004; 82: 1\u201317.","DOI":"10.1139\/o03-080"},{"key":"2022061623351548900_B3","doi-asserted-by":"crossref","unstructured":"Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat\u20082002; 68\u20139: 3\u201358.","DOI":"10.1016\/S0090-6980(02)00020-5"},{"key":"2022061623351548900_B4","doi-asserted-by":"crossref","unstructured":"Hirabayashi T, Shimizu T. Localization and regulation of cytosolic phospholipase A2. Biochim Biophys Acta\u20082000; 1488: 124\u201338.","DOI":"10.1016\/S1388-1981(00)00115-3"},{"key":"2022061623351548900_B5","doi-asserted-by":"crossref","unstructured":"Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta\u20082006; 1761: 1246\u201359.","DOI":"10.1016\/j.bbalip.2006.07.011"},{"key":"2022061623351548900_B6","doi-asserted-by":"crossref","unstructured":"Mariggio\u0300 S, Sebastia\u0300 J, Filippi BM, et al. A novel pathway of cell growth regulation mediated by a PLA2\u03b1-derived phosphoinositide metabolite. FASEB J\u20082006; 20: 2567\u20139.","DOI":"10.1096\/fj.05-5397fje"},{"key":"2022061623351548900_B7","doi-asserted-by":"crossref","unstructured":"Kimura T, Van Keymeulen A, Golstein J, et al. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev\u20082001; 22: 631\u201356.","DOI":"10.1210\/edrv.22.5.0444"},{"key":"2022061623351548900_B8","doi-asserted-by":"crossref","unstructured":"Valitutti S, Cucchi P, Colletta G, Di Filippo C, Corda D. Transformation by the k-ras oncogene correlates with increases in phospholipase A2 activity, glycerophosphoinositol production and phosphoinositide synthesis in thyroid cells. Cell Signal\u20081991; 3: 321\u201332.","DOI":"10.1016\/0898-6568(91)90061-X"},{"key":"2022061623351548900_B9","doi-asserted-by":"crossref","unstructured":"Corda D, Iurisci C, Berrie CP. Biological activities and metabolism of the lysophosphoinositides and glycerophosphoinositols. Biochim Biophys Acta\u20082002; 1582: 52\u201369.","DOI":"10.1016\/S1388-1981(02)00137-3"},{"key":"2022061623351548900_B10","doi-asserted-by":"crossref","unstructured":"Alonso T, Morgan RO, Marvizon JC, Zarbl H, Santos E. Malignant transformation by ras and other oncogenes produces common alterations in inositol phospholipid signaling pathways. Proc Natl Acad Sci U S A\u20081988; 85: 4271\u20135.","DOI":"10.1073\/pnas.85.12.4271"},{"key":"2022061623351548900_B11","doi-asserted-by":"crossref","unstructured":"Berrie CP, Iurisci C, Corda D. Membrane transport and in vitro metabolism of the Ras cascade messenger, glycerophosphoinositol 4-phosphate. Eur J Biochem\u20081999; 266: 413\u20139.","DOI":"10.1046\/j.1432-1327.1999.00870.x"},{"key":"2022061623351548900_B12","doi-asserted-by":"crossref","unstructured":"Berrie CP, Dragani LK, van der Kaay J, et al. Maintenance of PtdIns45P2 pools under limiting inositol conditions, as assessed by liquid chromatography-tandem mass spectrometry and PtdIns45P2 mass evaluation in Ras-transformed cells. Eur J Cancer\u20082002; 38: 2463\u201375.","DOI":"10.1016\/S0959-8049(02)00485-9"},{"key":"2022061623351548900_B13","doi-asserted-by":"crossref","unstructured":"Melillo RM, Castellone MD, Guarino V, et al. The RET\/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest\u20082005; 115: 1068\u201381.","DOI":"10.1172\/JCI200522758"},{"key":"2022061623351548900_B14","doi-asserted-by":"crossref","unstructured":"Santoro M, Melillo RM, Carlomagno F, Vecchio G, Fusco A. Minireview: RET: normal and abnormal functions. Endocrinology\u20082004; 145: 5448\u201351.","DOI":"10.1210\/en.2004-0922"},{"key":"2022061623351548900_B15","doi-asserted-by":"crossref","unstructured":"Santoro M, Carlomagno F, Melillo RM, Fusco A. Dysfunction of the RET receptor in human cancer. Cell Mol Life Sci\u20082004; 61: 2954\u201364.","DOI":"10.1007\/s00018-004-4276-8"},{"key":"2022061623351548900_B16","doi-asserted-by":"crossref","unstructured":"Ichihara M, Murakumo Y, Takahashi M. RET and neuroendocrine tumors. Cancer Lett\u20082004; 204: 197\u2013211.","DOI":"10.1016\/S0304-3835(03)00456-7"},{"key":"2022061623351548900_B17","doi-asserted-by":"crossref","unstructured":"Fagin JA. How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy. J Endocrinol\u20082004; 183: 249\u201356.","DOI":"10.1677\/joe.1.05895"},{"key":"2022061623351548900_B18","doi-asserted-by":"crossref","unstructured":"Ono T, Yamada K, Chikazawa Y, et al. Characterization of a novel inhibitor of cytosolic phospholipase A2\u03b1, pyrrophenone. Biochem J\u20082002; 363: 727\u201335.","DOI":"10.1042\/bj3630727"},{"key":"2022061623351548900_B19","doi-asserted-by":"crossref","unstructured":"Ryan AJ, Wedge SR. ZD6474\u2014a novel inhibitor of VEGFR and EGFR tyrosine kinase activity. Br J Cancer\u20082005; 92 Suppl 1: S6\u201313.","DOI":"10.1038\/sj.bjc.6602603"},{"key":"2022061623351548900_B20","doi-asserted-by":"crossref","unstructured":"Fusco A, Berlingieri MT, Di Fiore PP, et al. One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol Cell Biol\u20081987; 7: 3365\u201370.","DOI":"10.1128\/mcb.7.9.3365-3370.1987"},{"key":"2022061623351548900_B21","doi-asserted-by":"crossref","unstructured":"Ohta K, Endo T, Haraguchi K, Hershman JM, Onaya T. Ligands for peroxisome proliferator-activated receptor \u03b3 inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells. J Clin Endocrinol Metab\u20082001; 86: 2170\u20137.","DOI":"10.1210\/jcem.86.5.7493"},{"key":"2022061623351548900_B22","doi-asserted-by":"crossref","unstructured":"Ishizaka Y, Ushijima T, Sugimura T, Nagao M. cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line. Biochem Biophys Res Commun\u20081990; 168: 402\u20138.","DOI":"10.1016\/0006-291X(90)92335-W"},{"key":"2022061623351548900_B23","doi-asserted-by":"crossref","unstructured":"Pettus BJ, Bielawska A, Subramanian P, et al. Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. J Biol Chem\u20082004; 279: 11320\u20136.","DOI":"10.1074\/jbc.M309262200"},{"key":"2022061623351548900_B24","unstructured":"Falasca M, Silletta MG, Carvelli A, et al. Signalling pathways involved in the mitogenic action of lysophosphatidylinositol. Oncogene\u20081995; 10: 2113\u201324."},{"key":"2022061623351548900_B25","doi-asserted-by":"crossref","unstructured":"Berrie CP, Iurisci C, Piccolo E, Bagnati R, Corda D. Analysis of the phosphoinositides and their aqueous metabolites. Methods Enzymol 2007;434:187\u2013232.","DOI":"10.1016\/S0076-6879(07)34011-1"},{"key":"2022061623351548900_B26","doi-asserted-by":"crossref","unstructured":"Dragani LK, Berrie CP, Corda D, Rotilio D. Analysis of glycerophosphoinositol by liquid chromatography-electrospray ionisation tandem mass spectrometry using a \u03b2-cyclodextrin-bonded column. J Chromatogr B\u20082004; 802: 283\u20139.","DOI":"10.1016\/j.jchromb.2003.12.002"},{"key":"2022061623351548900_B27","doi-asserted-by":"crossref","unstructured":"Brondello JM, Brunet A, Pouyssegur J, McKenzie FR. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42\/p44MAPK cascade. J Biol Chem\u20081997; 272: 1368\u201376.","DOI":"10.1074\/jbc.272.2.1368"},{"key":"2022061623351548900_B28","unstructured":"Carlomagno F, Vitagliano D, Guida T, et al. ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases. Cancer Res\u20082002; 62: 7284\u201390."},{"key":"2022061623351548900_B29","unstructured":"Kimura ET, Nikiforova MN, Zhu Z, et al. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res\u20082003; 63: 1454\u20137."},{"key":"2022061623351548900_B30","doi-asserted-by":"crossref","unstructured":"Church WB, Inglis AS, Tseng A, et al. A novel approach to the design of inhibitors of human secreted phospholipase A2 based on native peptide inhibition. J Biol Chem\u20082001; 276: 33156\u201364.","DOI":"10.1074\/jbc.M101272200"},{"key":"2022061623351548900_B31","doi-asserted-by":"crossref","unstructured":"Ackermann EJ, Conde-Frieboes K, Dennis EA. Inhibition of macrophage Ca2+-independent phospholipase A2 by bromoenol lactone and trifluoromethyl ketones. J Biol Chem\u20081995; 270: 445\u201350.","DOI":"10.1074\/jbc.270.1.445"},{"key":"2022061623351548900_B32","doi-asserted-by":"crossref","unstructured":"Hayashi H, Ichihara M, Iwashita T, et al. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor. Oncogene\u20082000; 19: 4469\u201375.","DOI":"10.1038\/sj.onc.1203799"},{"key":"2022061623351548900_B33","doi-asserted-by":"crossref","unstructured":"Castellone MD, Cirafici AM, De Vita G, et al. Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET\/PTC oncogenes. Oncogene\u20082003; 22: 246\u201355.","DOI":"10.1038\/sj.onc.1206112"},{"key":"2022061623351548900_B34","doi-asserted-by":"crossref","unstructured":"Gordon RD, Leighton IA, Campbell DG, et al. Cloning and expression of cystolic phospholipase A2 (cPLA2) and a naturally occurring variant. Phosphorylation of Ser505 of recombinant cPLA2 by p42 mitogen-activated protein kinase results in an increase in specific activity. Eur J Biochem\u20081996; 238: 690\u20137.","DOI":"10.1111\/j.1432-1033.1996.0690w.x"},{"key":"2022061623351548900_B35","doi-asserted-by":"crossref","unstructured":"Kumar S, Jiang MS, Adams JL, Lee JC. Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem Biophys Res Commun\u20081999; 263: 825\u201331.","DOI":"10.1006\/bbrc.1999.1454"},{"key":"2022061623351548900_B36","doi-asserted-by":"crossref","unstructured":"Basolo F, Giannini R, Monaco C, et al. Potent mitogenicity of the RET\/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma. Am J Pathol\u20082002; 160: 247\u201354.","DOI":"10.1016\/S0002-9440(10)64368-4"},{"key":"2022061623351548900_B37","doi-asserted-by":"crossref","unstructured":"Vitagliano D, Portella G, Troncone G, et al. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. Oncogene\u20082006; 25: 5467\u201374.","DOI":"10.1038\/sj.onc.1209527"},{"key":"2022061623351548900_B38","doi-asserted-by":"crossref","unstructured":"Pierotti MA. Chromosomal rearrangements in thyroid carcinomas: a recombination or death dilemma. Cancer Lett\u20082001; 166: 1\u20137.","DOI":"10.1016\/S0304-3835(01)00439-6"},{"key":"2022061623351548900_B39","doi-asserted-by":"crossref","unstructured":"Alberti L, Carniti C, Miranda C, Roccato E, Pierotti MA. RET and NTRK1 proto-oncogenes in human diseases. J Cell Physiol\u20082003; 195: 168\u201386.","DOI":"10.1002\/jcp.10252"},{"key":"2022061623351548900_B40","doi-asserted-by":"crossref","unstructured":"Fusco A, Viglietto G, Santoro M. A new mechanism of BRAF activation in human thyroid papillary carcinomas. J Clin Invest\u20082005; 115: 20\u20133.","DOI":"10.1172\/JCI200523987"},{"key":"2022061623351548900_B41","doi-asserted-by":"crossref","unstructured":"Nakanishi M, Rosenberg DW. Roles of cPLA2\u03b1 and arachidonic acid in cancer. Biochim Biophys Acta\u20082006; 1761: 1335\u201343.","DOI":"10.1016\/j.bbalip.2006.09.005"},{"key":"2022061623351548900_B42","doi-asserted-by":"crossref","unstructured":"Hong KH, Bonventre JC, O'Leary E, Bonventre JV, Lander ES. Deletion of cytosolic phospholipase A2 suppresses ApcMin-induced tumorigenesis. Proc Natl Acad Sci U S A\u20082001; 98: 3935\u20139.","DOI":"10.1073\/pnas.051635898"},{"key":"2022061623351548900_B43","doi-asserted-by":"crossref","unstructured":"Takaku K, Sonoshita M, Sasaki N, et al. Suppression of intestinal polyposis in ApcD716 knockout mice by an additional mutation in the cytosolic phospholipase A2 gene. J Biol Chem\u20082000; 275: 34013\u20136.","DOI":"10.1074\/jbc.C000586200"},{"key":"2022061623351548900_B44","doi-asserted-by":"crossref","unstructured":"Dong M, Guda K, Nambiar PR, et al. Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis\u20082003; 24: 307\u201315.","DOI":"10.1093\/carcin\/24.2.307"},{"key":"2022061623351548900_B45","doi-asserted-by":"crossref","unstructured":"Mariggio\u0300 S, Bavec A, Natale E, et al. Ga13 mediates activation of the cytosolic phospholipase A2\u03b1 through fine regulation of ERK phosphorylation. Cell Signal\u20082006; 18: 2200\u20138.","DOI":"10.1016\/j.cellsig.2006.05.003"},{"key":"2022061623351548900_B46","doi-asserted-by":"crossref","unstructured":"De Falco V, Castellone MD, De Vita G, et al. RET\/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase. Cancer Res\u20082007; 67: 381\u201390.","DOI":"10.1158\/0008-5472.CAN-06-0981"},{"key":"2022061623351548900_B47","doi-asserted-by":"crossref","unstructured":"Segouffin-Cariou C, Billaud M. Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase\/AKT signaling pathway. J Biol Chem\u20082000; 275: 3568\u201376.","DOI":"10.1074\/jbc.275.5.3568"},{"key":"2022061623351548900_B48","doi-asserted-by":"crossref","unstructured":"Melillo RM, Santoro M, Ong SH, et al. Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol Cell Biol\u20082001; 21: 4177\u201387.","DOI":"10.1128\/MCB.21.13.4177-4187.2001"},{"key":"2022061623351548900_B49","doi-asserted-by":"crossref","unstructured":"Borrello MG, Alberti L, Arighi E, et al. The full oncogenic activity of Ret\/ptc2 depends on tyrosine 539, a docking site for phospholipase C\u03b3. Mol Cell Biol\u20081996; 16: 2151\u201363.","DOI":"10.1128\/MCB.16.5.2151"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/24\/11769\/2580170\/11769.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/24\/11769\/2580170\/11769.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:05:17Z","timestamp":1655438717000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/24\/11769\/534398\/Cytosolic-Phospholipase-A2-Regulates-Cell-Growth"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,15]]},"references-count":49,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2007,12,18]]},"published-print":{"date-parts":[[2007,12,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-1997","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,15]]}}}